Skip to content

QuickVue 20125

by Quidel Corp.

Ref 20125Model QuickVue Dipstick Strep A 25-Test Kit

QuickVue 20125 is a device classified as IVD General (EU), Class I (US) made by Quidel Corp., registered in EUDAMED on 4 Nov 2026 (Basic UDI-DI B-30014613201250), cleared under FDA 510(k) K011097 on 8 May 2001 and listed in FDA GUDID since 10 Nov 2018 (UDI-DI 30014613201250), active as of 7 Nov 2026. 2 FDA recalls are linked to it.

Active European Union and United States. Also listed in GUDID (US).

CE IVDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

2 ongoing

This device is named in the recall

Documents

None, self-declared

Class I: no certifier involved

510(k) K011097

FDA submission, from GUDID

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-30014613201250 Basic UDI-DI 30014613201250UDI-DIDate4 Nov 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number30014613201250 UDI-DI Date10 Nov 2018ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE GUDID from GUDID Substantially Equivalent · Traditional NumberK011097 Date8 May 2001DecidedStatusActive

Official records

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI B-30014613201250 registered 4 Nov 2026 Active
  • FDA 510(k) K011097 decided 8 May 2001 Active
  • FDA GUDID UDI-DI 30014613201250 listed 10 Nov 2018 Listed

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Recalls

2 recalls · 2 ongoing · FDA

    • Ongoing Z-2169-2026 FDA Class II initiated 6 Apr 2026

    Product has the potential for false positive results

    • Ongoing Z-2545-2025 FDA Class II initiated 17 Jun 2025

    Dipstick strep A test has potential for false positive results.

Timeline

5 dated events

  1. Cleared FDA 510(k) K011097
  2. Listed FDA GUDID 30014613201250
  3. Recall initiated FDA recalls Z-2545-2025
  4. Recall initiated FDA recalls Z-2169-2026
  5. Registered EUDAMED B-30014613201250

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Trade name
QuickVue Dipstick Strep A 25-Test Kit EUDAMED
QuickVue GUDID
Generic name
Beta-haemolytic Group A Streptococcus antigen IVD, kit, rapid ICT, clinical
Model / Ref / Catalog
20125, QuickVue Dipstick Strep A 25-Test Kit
Primary DI / UDI-DI
30014613201250
Basic UDI-DI
B-30014613201250
510(k) Number
FDA product code
GTY
EMDN code
W0105011101 Streptococcal direct antigen detection
GMDN term
Beta-haemolytic Group A Streptococcus antigen IVD, kit, rapid ICT, clinical
Device class
Class IVD General EUDAMED
Class I GUDID
Regulation number
866.3740
EU registration type
Legacy device (under a directive)
EU market of registration
Austria
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
GUDID
Class I

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class I in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under STREPTOCOCCAL DIRECT ANTIGEN DETECTION.

Other devices from Quidel Corp.

See all devices from Quidel Corp. →

Properties

  • Single use
  • Contains animal tissues or cells
  • IVD kit
  • Near-patient testing
  • Professional testing
  • Prescription use
  • Convenience kit
  • Expiration date
Other properties (18, all answered No)